GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ORIC Pharmaceuticals Inc (STU:4TZ) » Definitions » Purchase Of Investment

ORIC Pharmaceuticals (STU:4TZ) Purchase Of Investment : €-186.96 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is ORIC Pharmaceuticals Purchase Of Investment?

ORIC Pharmaceuticals's purchase of investment for the three months ended in Mar. 2025 was €-59.81 Mil. It means ORIC Pharmaceuticals spent €59.81 Mil on purchasing investments. ORIC Pharmaceuticals's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was €-186.96 Mil.

Compared with last quarter (€-33.07 Mil in Dec. 2024 ), ORIC Pharmaceuticals spent more money on purchasing investments in Mar. 2025 (€-59.81 Mil).

ORIC Pharmaceuticals Purchase Of Investment Historical Data

The historical data trend for ORIC Pharmaceuticals's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ORIC Pharmaceuticals Purchase Of Investment Chart

ORIC Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial -185.35 -61.62 -224.79 -219.39 -240.58

ORIC Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -105.24 -45.42 -48.67 -33.07 -59.81

ORIC Pharmaceuticals Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-186.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ORIC Pharmaceuticals Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of ORIC Pharmaceuticals's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

ORIC Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ORIC Pharmaceuticals Inc (STU:4TZ) » Definitions » Purchase Of Investment
Comparable Companies
TSHA MAZE CKPT AUTL HRTX ARCT ORKA BNTC RIGL VSTM VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
ORIC:USA 4TZ:Germany
Address
240 E. Grand Avenue, 2nd Floor, South San Francisco, CA, USA, 94080
Website
https://www.oricpharma.com
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

ORIC Pharmaceuticals Headlines

No Headlines